Retour au classement

ExlService Holdings, Inc. (EXLS)

POSITIVE
TechnologyInformation Technology ServicesUnited States

Fondamental

78

Prix

$37.44

Capitalisation boursière

$5.78B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

ExlService Holdings, Inc., operates as a data and artificial intelligence (“AI”) company in the North America, the United Kingdom, Europe, and internationally. The company operates through Insurance; Healthcare and Life Sciences; Banking, Capital Markets, and Diversified Industries; and International Growth Markets. It provides digital operations and solutions and analytics-driven services, such as claims management, premium and benefit administration, agency management, account reconciliation, actuarial and risk analytics, policy research, digital marketing, underwriting support, new business acquisition, policy servicing, audit, surveys, billing and collection, commercial and residential survey, and customer service; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and Life Digital Suite platforms; and Subrosource software platform, an end-to-end subrogation platform. The company also offers health care services for care, utilization, and disease management; payment integrity; revenue optimization, customer engagement, and commercial analytics and regulatory support services; and digital operations and solutions. In addition, it provides financial planning and analysis, accounting, regulatory and statutory reporting, decision support, data management, and compliance services; consumer and commercial banking, credit card and payment services; fintech, wealth and retirement services; capital markets, utilities, retail and consumer packaged goods, communications, media and entertainment, travel and leisure, transportation and logistics, infrastructure, and other business services; property and casualty insurance, life insurance, disability insurance; and insurance brokers, reinsurers, annuity and retirement services. The company was founded in 1999 and is headquartered in New York, New York.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilan & Liquidités

Chiffre d'affaires

$2.16B

12 derniers mois (au 31/03/2026)

Résultat net

$252M

12 derniers mois (au 31/03/2026)

Flux de trésorerie libre

$298M

Capitaux propres totaux

$913M

Passif total

$790M

Ratio de liquidité général

2.66

Couverture des intérêts

18.78

Dette/EBITDA

1.40

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

Sous-évalué

Juste valeur

$53.84

Prix actuel

$37.44

Marge de sécurité

+30.5%

Fourchette de juste valeur

$35.00 - $72.69

Méthodes d'estimation

Analyst Target:$44.38
DCF:$100.85
PE-based:$22.45
Graham Growth:$79.75
EPV:$19.00
Consensus des analystes:Achat fort (14B / 2H / 0S)
Dernière surprise sur les résultats:+5.81%

Indicateurs de valorisation

Ratio P/E

23.99

ROE

27.5%

Ratio P/B

7.39

P/FCF

19.40

Marge brute

38.5%

ROIC

18.8%

Radar de rentabilité

Value Creation (Economic Moat)

ROIC

18.8%

WACC

8.5%

ROIC − WACC

+10.3 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Critères d'analyse fondamentale

Réussi (23)

  • EPS shows upward trend
  • EPS CAGR 6.89%
  • Price CAGR 14.04%
  • ROIC 18.8%
  • Gross Margin 38.5%
  • P/FCF 19.40
  • Debt/Equity ratio
  • Operating Margin 15.2%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 28.5%
  • Revenue Growth 5Y 16.9%
  • Analyst Consensus 88% Buy
  • Earnings Surprise avg 4.7%
  • PEG Ratio 0.88
  • Earnings Quality (OCF/NI) 1.39
  • Share Dilution -0.5%
  • Net Margin Trend 11.7% vs 11.4%
  • Piotroski F-Score 7/9

Échoué (4)

  • P/B Ratio 7.39
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)

Indisponible (1)

  • Dividend Payout NaN%

Score F de Piotroski

7/9

Santé financière solide

score
criteria

Qualité des bénéfices

1.39

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-0.5%

Rachat d'actions. Favorable aux actionnaires

Gouvernance

Équipe dirigeante

NomTitreÂge
Mr. Rohit KapoorCo-Founder, Chairman & CEO60
Mr. Vikas BhallaPresident and Head of AI Services & Operations53
Mr. Vivek JetleyPresident and Head of Insurance, Healthcare & Life Sciences50
Mr. Maurizio Nicolelli CPAExecutive VP & CFO57
Mr. Narasimha KiniExecutive Vice President of Banking & Capital Markets and Diversified Industries56
Ms. Bhavna Newle ChopraSenior Vice President in Operations Management-
Mr. Baljinder SinghExecutive VP, Global Chief Information Officer & Head of Enterprise Digital Transformation52
Mr. Andrew ThutHead of Investor Relations & Capital Markets-
Mr. Ajay Ayyappan J.D.Executive VP, General Counsel & Corporate Secretary47
Mr. Joel KatzSenior VP and Chief Compliance & Ethics Officer-

Risque d'audit

1

Risque du conseil

5

Risque de rémunération

1

Risque droits des actionnaires

4

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Latest News

Recent headlines for EXLS, sourced from Markets Gazette.

  • 3/11/2026NEGATIVE
    EXL Stock Down 41% Year Over Year as One Investor Reveals $68 Million Exit

    ExlService Holdings Inc. (EXLS) has experienced a significant 41% decline in its stock value over the past year. This downturn is highlighted by a substantial $68 million exit by a key investor, signaling a potential loss of confidence or a strategic shift. The company, which provides digital operations and analytics solutions to the insurance, healthcare, and life sciences sectors, faces increased scrutiny from the market. Investors are likely reassessing the company's growth prospects and competitive positioning in light of this exit and the substantial share price depreciation.

  • 2/25/2026NEUTRAL
    ExlService (EXLS) Q4 2025 Earnings Call Transcript

    Investors in ExlService (EXLS) are currently awaiting the release of the transcript from the company's fourth-quarter 2025 earnings call. While the event has been announced, specific details regarding key financial metrics such as revenue, earnings per share, and future guidance are not yet available. The market will closely scrutinize this information to assess the company's performance during the period and its growth prospects. The absence of concrete data currently prevents a directional judgment on the potential impact these results might have on the stock. The reaction of EXLS shares will entirely depend on the strength of the numbers presented and the future projections outlined by management.

via Markets Gazette